openPR Logo
Press release

HeartPlace Adopts Emerge Clinical Decision Support for 25 Hospitals, 31 Clinics

11-13-2012 05:35 PM CET | IT, New Media & Software

Press release from: Emerge Clinical Solutions

/ PR Agency: Power Public Relations
(Dallas, Texas) November 9, 2012 – Emerge Clinical Solutions, the creator of premier clinical decision support software, today announced HeartPlace is adapting its software system in 31 clinics throughout the Dallas and Fort Worth areas.

HeartPlace is the largest independent cardiology group in the United States and the largest cardiology group in the country to use electronic medicals records. HeartPlace has been using Nextgen for 8 years; the group implemented the technology long before most medical practices were open to electronic recordkeeping.

“Emerge’s support suite was a clear choice because it merges seamlessly with any electronic medical records system, particularly Nextgen. The software helps doctors do their jobs more efficiently, allowing them to have raised awareness of frequently missed diagnoses and implement appropriate, evidence-based care paths and diagnostic testing,” said Dr. Ken Johnson, HeartPlace Chief Strategy Officer.

Emerge runs comprehensive patient data through a unique agnostic algorithm that is adept at analyzing patients who are traditionally more difficult to diagnose, including women and certain minorities.

Emerge’s clinical decision support streamlines the diagnosis process and has been proven to increase identification of certain cardiac diseases by as much as 300 percent. When running a patient’s data and complete medical history through its patented algorithm, the software makes more than 8,000 calculations in seconds to achieve a precise diagnosis and define a detailed clinical pathway that leads to improved, evidence-based clinical decision making.

“Electronic medical records are no longer a dream for the future. They’re a reality that patients are beginning to demand, and clinical decision support is a natural partnership with these systems. Emerge helps doctors make a clearer, more refined diagnosis and puts decades of medical knowledge at their fingertips. We’re helping great doctors make each patient interaction even more excellent,” said Scott Finfer, Emerge CEO.

HeartPlace treats thousands of Texans every year and specializes in a variety of cardiac issues including thoracic surgery, congestive heart failure, electrophysiology, general and preventative cardiology, interventional cardiology, and vascular and endovascular medicine.

By adopting Emerge, HeartPlace joins several other major cardiology practices that are ahead of the medical technology curve. Cardiology Associates of Northern Mississippi, a leading regional health practice, successfully integrated Emerge with its GE Healthcare Centricity records system in 2011. The nationally renowned Oklahoma Heart Hospital adopted the system in August 2012.

“HeartPlace is an incredibly well respected cardiology group whose physicians regularly win awards and are recognized by the community, major publications, and their peers. It’s an honor to work with these doctors and help them do their jobs with more ease and efficiency so they can focus on their patients. We look forward to making both the doctor and patient experiences more fulfilling,” said Finfer.

About Emerge Clinical Solutions
Emerge Clinical Solutions is the creator of software solution developed by cardiologists to help medical providers and administrators improve the quality of cardiologic care to combat the nation’s number one killer, cardiac diseases. The software helps doctors increase condition recognition rates for high-risk patients, which ensures that patients receive the appropriate care at the appropriate time.

By assisting doctors with advanced diagnosis Emerge prevents costly, time-consuming and inappropriate tests and procedures. Emerge software also identifies high risk conditions quicker and with more efficiency. Medical emergencies are avoided and addressed with outpatient procedures. This proactive technology reduces emergency room visits and time in intensive care or worse… death. To learn more, please visit www.emergecds.com.

About HeartPlace
Founded almost 50 years ago, HeartPlace is the past, present and future of cardiology in North Texas. From its humble beginnings, HeartPlace has flourished as the oldest and most expansive cardiovascular group in North Texas and now proudly has established itself as the largest private practice cardiovascular services group in the United States.

HeartPlace has been an innovator in all facets of cardiovascular disease introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. That dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services available anywhere.
With over 25 locations throughout North Texas, HeartPlace has developed strong ties to local hospitals and the community at large. These relationships have allowed HeartPlace to provide comprehensive cardiovascular care throughout the Metroplex with the utmost attention to quality and compassionate care. HeartPlace physicians are dedicated to providing leading edge technology including prevention, early detection, and treatment of cardiovascular diseases.

HeartPlace’s commitment to quality is exemplified by its emphasis on board certification for all of its physicians as well as its pursuit for uniform accreditation for all of its office-based imaging centers. Further, the physicians of HeartPlace are champions for the utilization of the latest diagnostic and therapeutic technologies available.

HeartPlace prides itself on being able to deliver quality care whether it is a simple problem such as blood pressure control or complicated procedures such as robotic surgery or cardiac transplantation.

Our physicians are consistently mentioned among the best in Texas and providing the highest level of patient care and satisfaction remains their number one goal. With HeartPlace, the future of cardiology is truly here.

Emerge Clinical Decision Solutions
3131 McKinney Ave.
Dallas, TX 75204

Jansen White
jansen@powerpublicrelations.com
512.818.7202

Amy Power
amy@powerpublicrelations.com
214. 693.2146

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HeartPlace Adopts Emerge Clinical Decision Support for 25 Hospitals, 31 Clinics here

News-ID: 242859 • Views:

More Releases from Emerge Clinical Solutions

Emerge Hires Ori Zakin as New Chief Technology Officer and Opens International O …
(Dallas) September 18, 2013 – Emerge Clinical Decision Solutions, creator of premier cardiologic clinical decision support software, today announced Ori Zakin as the company’s new chief technology officer and the opening of a research and development office in Israel. Emerge is a real time clinical decision support solution that helps doctors increase efficiency of patient care. By running comprehensive patient data through a patented algorithm, Emerge performs more than 8,000 calculations
Emerge Clinical Decisions Solutions Joins Short List of CDS Software Certified b …
(Dallas) September 11, 2013 – Emerge Clinical Decision Solutions today announced its accreditation as the first cardiology-specific CDS software in the country to be certified for meaningful use. Emerge has been tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program. This EHR software is compliant in accordance with the criteria adopted by the Secretary of the U.S. Department of
Oklahoma Heart Hospital Partners with Emerge to Add Clinical Decision Support to …
(Dallas, Texas) October 2, 2012 – Oklahoma hearts just got a little healthier. Emerge Clinical Solutions, the creator of premier clinical decision support software, today announced Oklahoma Heart Hospital (OHH) is adding its software systems to its North and South Campus hospitals as well as 60 health clinics. OHH operates state of the art facilities that are consistently rated as the best in the country. It was the first all digital

All 4 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an